Once-quiet device makers rule life-sciences roost
For years, medical devices took a quiet support role alongside high-flying drug manufacturing and biotechnology industries known for rolling out new $1 billion-a-year products. Suddenly that's no longer true, especially in Massachusetts. (Full article: 574 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly





